|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.1 ~. t8 \1 F6 h+ W( b
Author: Mizrak, D.; Brittan, M.; Alison, M. R.
5 R0 [4 G4 z$ x2 }8 KSource: J Pathol, 2008, 214(1): 3-9
; l3 x* W4 a5 |# b6 t+ f5 [2 g. I8 J/ n4 ~1 \7 ]& |
Title: Focus on molecules: prominin-1 (CD133).5 s1 T* K( \- v8 ~
Author: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
! f) i& p' }- {9 C8 m& p8 vSource: Exp Eye Res, 2007, 85(5): 585-5863 g) L5 N: @& {- @
2 u5 x% m2 n8 E7 s; W1 _Title: CD133.5 _2 W6 D& C' V& _3 ]3 e
Author: Piechaczek, C., Q4 A" x! @$ S) {5 E' |' Y7 V) Z
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-102) T. o* o' b% z
) y2 ?% {8 g) w! f2 P$ ?Title: CD133 as a marker for cancer stem cells: progresses and concerns.
~% { [0 b; H' F/ C$ [' bAuthor: Wu, Y.; Wu, P. Y.8 P9 g. v3 z/ p7 m1 L: W
Source: Stem Cells Dev, 2009, 18(8): 1127-1134
5 s. \! s9 U- p% p$ m! b) S ~6 X( n5 h: {' D' L/ l4 u; b! V1 g8 \, ?6 k
Title: Risk and benefit of CD133+ progenitors.
- \$ K2 `5 X$ C% PAuthor: Ascione, R.; Madeddu, P.
; N ^" p8 y# t9 w4 }7 ^& x) H" iSource: Circ Res, 2009, 105(2): e2
2 J+ h& `$ r) i# p* g3 |6 }0 W0 p! }' Z2 r) x9 c/ s8 F
Title: Targeting CD133 antigen in cancer.
- q) u4 Y5 c. x; K3 t) {% z9 aAuthor: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...); M% G5 b% Y2 ]
Source: Expert Opin Ther Targets, 2009, 13(7): 823-837
* b6 K4 `4 y, F0 [' }2 u# D3 h# j$ l- ^/ k
Title: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
. `. W! t8 T- G3 l; v7 R* r# Y8 BAuthor: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)
5 |# p( D# D: uSource: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
